Manali Petrochemicals has reported its audited financial results for the quarter and year ended March 31, 2026, delivering strong growth across key metrics. The company recorded a consolidated net profit of INR 1,299.50 crore for the fiscal year, a significant increase from INR 293.10 crore in the previous year. Total income for the year stood at INR 10,698.50 crore, compared to INR 9,216.30 crore in FY25. The results reflect improved raw material efficiencies, better realizations, and steady contributions from overseas subsidiaries.

Q4 Financial Performance

For the quarter ended March 31, 2026, Manali Petrochemicals delivered a notable year-on-year improvement across all key parameters. Consolidated net profit came in at 290m Rupees, compared to 108m Rupees in the same quarter of the previous year. Revenue for the quarter stood at 3b Rupees versus 2.3b Rupees on a YoY basis. EBITDA for the quarter was 434m Rupees against 210m Rupees in the corresponding prior-year period, with EBITDA margin expanding significantly to 14.85% from 9.13% YoY. The standalone total income for the quarter was INR 2,567.10 crore, up from INR 2,061.40 crore in the previous quarter, while the standalone Profit Before Tax stood at INR 327.40 crore, compared to INR 50.90 crore in the preceding quarter.

The following table presents the Q4 year-on-year performance highlights:

Full-Year Consolidated Results

The annual performance reflects a strong recovery and growth trajectory for the company. The following table summarises the consolidated financial performance for the year and quarter:

The board has recommended a dividend of INR 0.50 per equity share, representing 10%, subject to the approval of shareholders at the ensuing Annual General Meeting.

Board Decisions

The Board of Directors, in their meeting held on May 21, 2026, approved the audited financial results under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board also approved the re-appointment of Mr. Thanjavur Kanakaraj Arun as an Independent Director for a second term of five years effective from September 29, 2026, subject to shareholder approval. Additionally, the board approved seeking member consent through a postal ballot for this re-appointment and for revising the remuneration of Mr. R Chandrasekar, MD & CEO, and Mr. G R Sridhar, Wholetime Director.

Management Commentary

The company attributed the improved performance to strategic raw material purchasing and selective market participation amid unfolding international events. Consolidated results were supported by the steady performance of overseas subsidiaries. Mr. Ashwin Muthiah, Chairman, noted that improved raw-material efficiencies, better realizations, and contributions from overseas subsidiaries supported the results. He emphasized the continuous focus on internal cost discipline and productivity gains. Management remains cautious on the near-term market outlook given continuing volatility in input costs and global trade conditions.

Manali Petrochemicals has achieved a significant milestone through its subsidiary PennWhite India Private Limited, which successfully inaugurated its manufacturing facility at Oragadam, Chennai, Tamil Nadu on 29 April 2026. This development marks an important expansion in the company's operational capabilities and manufacturing infrastructure for specialty chemicals.

Facility Details and Specifications

The newly opened plant at Oragadam represents a strategic investment by PennWhite India Private Limited to enhance its production capacity for foam control chemistry. The facility is designed to serve customer requirements in India and the wider Asian markets, operating under the same quality and manufacturing standards as PennWhite's existing facility in the United Kingdom.

Corporate Structure and Background

PennWhite India Private Limited operates as a wholly owned step-down subsidiary of Manali Petrochemicals Limited through PennWhite Limited, UK. The UK entity was acquired by Manali Petrochemicals in November 2022, with the Indian subsidiary incorporated in February 2024 to enhance business development in the Indian and broader Asian market.

Leadership Statements

Devaki Muthiah Chardon, Chairperson of PennWhite Limited (UK), emphasized the strategic importance of the facility: "Our PennWhite India plant represents far more than an expansion of our operations. It establishes a strong and strategic presence for PennWhite in Asia, enabling us to better serve our regional customers while opening the door to new partnerships and opportunities."

Tobias Tasche, Chief Executive Officer of PennWhite Limited, UK, highlighted the facility's role in the company's India strategy: "The inauguration of this facility at Oragadam is a significant step in our India strategy. Since MPL's acquisition of PennWhite in 2022, we have steadily expanded our presence — incorporating PennWhite India in 2024, acquiring a defoamer business in India last year, and now commissioning this plant."

Strategic Market Position

The Chennai facility positions PennWhite India to manufacture over 200 products, including foam control agents under the FoamDoctor® brand, silicone oils, and other specialty chemicals. The company serves customers in over 40 countries across applications including food processing, wastewater treatment, printing, oil industry operations, coatings, manufacturing, and construction. The plant has been awarded ISO 9001 certification, with additional quality and food safety accreditations currently underway.